| Page 848 | Kisaco Research
 

Ruth Coleman

Venture Capital Investor
Mercia Asset Management

Ruth Coleman

Venture Capital Investor
Mercia Asset Management

Ruth Coleman

Venture Capital Investor
Mercia Asset Management
 

Malin Riddarström

Head of Product Growth
Natural Cycles

Malin Riddarström

Head of Product Growth
Natural Cycles

Malin Riddarström

Head of Product Growth
Natural Cycles
 

Caroline Noublanche

CEO
Apricity

Caroline Noublanche

CEO
Apricity

Caroline Noublanche

CEO
Apricity
 

Danchen Zhao

Investment Director
MTIP

Danchen Zhao

Investment Director
MTIP

Danchen Zhao

Investment Director
MTIP
 

Diana Torgersen

Head of Innovation Ecosystem Integration
Organon

Diana Torgersen

Head of Innovation Ecosystem Integration
Organon

Diana Torgersen

Head of Innovation Ecosystem Integration
Organon
 

Magdelena Plotcyzk, PhD

Investment Associate
MTIP

Magdelena Plotcyzk, PhD

Investment Associate
MTIP

Magdelena Plotcyzk, PhD

Investment Associate
MTIP
 

Dirk Schneider

European Medical Affairs Lead, Immuno-oncology
GSK

Dirk Schneider

European Medical Affairs Lead, Immuno-oncology
GSK

Dirk Schneider

European Medical Affairs Lead, Immuno-oncology
GSK
 

Michelle Tsai

VP Global Commercial Strategy
Myovant Sciences

Michelle Tsai

VP Global Commercial Strategy
Myovant Sciences

Michelle Tsai

VP Global Commercial Strategy
Myovant Sciences
 

Eirini Rapti

Co-Founder & CEO
Inne

Eirini Rapti

Co-Founder & CEO
Inne

Eirini Rapti

Co-Founder & CEO
Inne
 

Eirini Rapti

Co-Founder & CEO
Inne

Eirini Rapti

Co-Founder & CEO
Inne

Eirini Rapti

Co-Founder & CEO
Inne